Search
-
Channel Performance Management
Read more about three focus areas to consider when measuring and managing channel performance.
-
Are We Ready to Share Again?
Revisit our recorded webinar to hear new research exploring current and potentially future shared mobility trends.
-
For Mobile Wallets, Restaurant Frustrations are an Opportunity
Brands should emphasize convenience in industries that are seeing long wait times for customers, particularly at restaurants.
-
Americans rank mental health, cancer, drug abuse, and obesity as nation’s top health issues after COVID
Waiting times and lack of staff are perceived as the biggest problems with most countries’ healthcare system while cost of treatment tops the list in the U.S.: 2021 Global Health Service Monitor
-
Oncology: the disease, dynamics & challenges of market research
The oncology treatment landscape rarely stands still, and its constant evolution affects all those involved: patients, their carers, cancer treaters, and treatment manufactures.
-
Women in Tech Roundtable: Innovation, Inclusion and Insights
Listen in to hear strategic career and business insights shared by some of the most talented female leaders in media, marketing, and technology today.
-
2021 Global Infrastructure Index finds Americans particularly frustrated and focused on the economic impact of improvements
Water supply, road infrastructure, and solar energy are most viewed as priority areas for infrastructure investment in the U.S.
-
Positive impact of intersectionality in advertising
The Unstereotype Alliance today released its new report “Beyond Gender 2: The Impact of Intersectionality in Advertising,” produced with support from LIONS and research conducted by Ipsos.
-
Doctors are the most trusted profession in the U.S. and across the world
No people trust their military more than Americans do; trust in teachers steady globally but lower in the U.S. than before the pandemic.
-
Ipsos clients honored for research in advertising
Advertising Research Foundation highlights campaigns by STEGLUJAN/Merck, Stella Artois and Gardasil 9/Merck.